Eiko Lifesciences share news, announcements and annual reports
BSE: 540204Chemicals & PetrochemicalsSmall Cap
EIKO LIFESCIENCES LIMITED · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2016
Last close ₹50.72down ₹0.80 (1.55%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹51.52.
30 Oct: open ₹52.64, high ₹52.93, low ₹50.27
52-week range of traded prices to 30 Oct 2026
₹43.00Low, 15 Sep 2026₹64.44High, 4 Nov 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹74 Cr3,149th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.08
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.07
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,609
Eiko Lifesciences board meetings
139 filed, newest first. Page 2 of 3.
Jun 2023
26 Jun · Board meeting
Meeting on 30 Jun 2023: rights issue of equity shares
May 2023
10 May · Board meeting
Meeting on 15 May 2023: rights issue of equity shares2 May · Board meeting
Meeting on 9 May 2023: audited results
Apr 2023
Jan 2023
25 Jan · Board meeting
Meeting on 31 Jan 2023: rights issue of equity shares, rights issue of equity shares with warrants, increase in authorised capital, preferential issue of shares and rights issue9 Jan · Board meeting
Meeting on 17 Jan 2023: quarterly results
Oct 2022
21 Oct · Board meeting
14 Oct · Board meeting
Meeting on 21 Oct 2022: quarterly results
Aug 2022
2 Aug · Board meeting
Meeting on 12 Aug 2022: quarterly results
Jun 2022
1 Jun · Board meeting
Meeting on 1 Jun 2022: annual general meeting
Apr 2022
22 Apr · Board meeting
13 Apr · Board meeting
Meeting on 22 Apr 2022: quarterly results
Jan 2022
28 Jan · Board meeting
Meeting on 8 Feb 2022: quarterly results
Oct 2021
20 Oct · Board meeting
Meeting on 2 Nov 2021: quarterly results
Aug 2021
Jul 2021
23 Jul · Board meeting
Meeting on 30 Jul 2021: quarterly results
May 2021
12 May · Board meeting
Meeting on 12 May 2021: preferential issue of shares
Apr 2021
12 Apr · Board meeting
Meeting on 20 Apr 2021: audited results
Mar 2021
1 Mar · Board meeting
Feb 2021
24 Feb · Board meeting
Meeting on 1 Mar 2021: preferential issue of shares
Jan 2021
28 Jan · Board meeting
Meeting on 10 Feb 2021: quarterly results
Nov 2020
12 Nov · Board meeting
12 Nov · Board meeting
5 Nov · Board meeting
Meeting on 12 Nov 2020: quarterly results and increase in authorised capital
Oct 2020
Sep 2020
25 Sep · Board meeting
Meeting on 3 Oct 20201 Sep · Board meeting
Meeting on 8 Sep 2020: annual general meeting and quarterly results